PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
1534527-7	1992	Zymosan increased (p less than .03) ileal and hepatic xanthine oxidase activity, while reducing (p less than .01) antioxidant (catalase) activity.	Zymosan	0-7	xanthine dehydrogenase	Mus musculus	54-70	
1534527-4	1992	Since zymosan-induced bacterial translocation may be mediated by xanthine oxidase-generated oxidants, bacterial translocation was measured in mice pretreated with the xanthine oxidase inhibitor, allopurinol.	Zymosan	6-13	xanthine dehydrogenase	Mus musculus	65-81	
1534527-4	1992	Since zymosan-induced bacterial translocation may be mediated by xanthine oxidase-generated oxidants, bacterial translocation was measured in mice pretreated with the xanthine oxidase inhibitor, allopurinol.	Zymosan	6-13	xanthine dehydrogenase	Mus musculus	167-183	
1740792-3	1992	At nonlethal doses (0.1 and 0.5 mg/g body weight), zymosan caused injury to the intestinal mucosa, increased intestinal xanthine oxidase activity, and promoted bacterial translocation in a dose-dependent fashion.	Zymosan	51-58	xanthine dehydrogenase	Mus musculus	120-136	
1740792-4	1992	Inhibition or inactivation of xanthine oxidase activity was effective in reducing mucosal injury and bacterial translocation when zymosan was injected at 0.1 mg/g but not at 0.5 mg/g body weight.	Zymosan	130-137	xanthine dehydrogenase	Mus musculus	30-46